Affiliation:
1. Department of Otolaryngology–Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
2. Department of Otolaryngology–Head and Neck Surgery, Baylor College of Medicine, Houston, Texas
3. Department of Hearing and Speech Sciences, Vanderbilt University Medical Center, Nashville, Tennessee
Abstract
Abstract
Objective
To report speech recognition outcomes and processor use based on timing of cochlear implant (CI) activation.
Study Design
Retrospective cohort.
Setting
Tertiary referral center.
Patients
A total of 604 adult CI recipients from October 2011 to March 2022, stratified by timing of CI activation (group 1: ≤10 d, n = 47; group 2: >10 d, n = 557).
Main Outcome Measures
Average daily processor use; Consonant-Nucleus-Consonant (CNC) and Arizona Biomedical (AzBio) in quiet at 1-, 3-, 6-, and 12-month visits; time to peak performance.
Results
The groups did not differ in sex (p = 0.887), age at CI (p = 0.109), preoperative CNC (p = 0.070), or preoperative AzBio in quiet (p = 0.113). Group 1 had higher median daily processor use than group 2 at the 1-month visit (12.3 versus 10.7 h/d, p = 0.017), with no significant differences at 3, 6, and 12 months. The early activation group had superior median CNC performance at 3 months (56% versus 46%, p = 0.007) and 12 months (60% versus 52%, p = 0.044). Similarly, the early activation group had superior median AzBio in quiet performance at 3 months (72% versus 59%, p = 0.008) and 12 months (75% versus 68%, p = 0.049). Both groups were equivalent in time to peak performance for CNC and AzBio. Earlier CI activation was significantly correlated with higher average daily processor use at all follow-up intervals.
Conclusion
CI activation within 10 days of surgery is associated with increased early device usage and superior speech recognition at both early and late follow-up visits. Timing of activation and device usage are modifiable factors that can help optimize postoperative outcomes in the CI population.
Publisher
Ovid Technologies (Wolters Kluwer Health)